Tempest Therapeutics TPST
NASDAQ TPST
$0.81 -0.03 (-3.38%)
At close: Oct 1, 2026 · 4:00 PM EDT

Tempest Therapeutics (TPST) Cash from Financing Activities (2012 - 2025)

Updated

Tempest Therapeutics' Cash from Financing Activities was $3.77 million in Q4 2025, down 79.0% from $17.95 million a year earlier.

Analysis

Tempest Therapeutics (TPST) Cash from Financing Activities (2012 - 2025) Analysis & Trends

For FY2025, Cash from Financing Activities at Tempest Therapeutics came in at $4.26 million, down 82.6% from FY2024.

  • Cash from Financing Activities shows a five-year compound annual growth rate of -34.2% (FY2020 to FY2025).
  • In earlier years, Cash from Financing Activities was $24.5 million in FY2024 (-31.2%), $35.6 million in FY2023 (+212.2%), $11.4 million in FY2022 (-80.7%) and $59.06 million in FY2021 (+70.7%).
  • Quarterly Cash from Financing Activities has moved between -$4.73 million (Q4 2022) and $40.96 million (Q2 2021) over five years.
  • Compared with a year earlier, Cash from Financing Activities has declined for three straight quarters, with growth averaging 151.1% over the last six quarters.
  • The best year-over-year quarter for Cash from Financing Activities over five years was Q1 2024 (growth of 922.7%); the worst was Q3 2025 (a decline of 99.2%).
  • Per Business Quant data, TPST's Cash from Financing Activities in the three quarters before Q4 2025 was $13,000 (Q3 2025), $1.2 million (Q2 2025) and -$721,000 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -8.78 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -5.05 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -47.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 2.34 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -426.70 Mn
10 Tempest Therapeutics 4.09 Mn -26.23 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 3.77 Mn
Sep 30, 2025 13,000.00
Jun 30, 2025 1.20 Mn
Mar 31, 2025 -721,000.00
Dec 31, 2024 17.95 Mn
Sep 30, 2024 1.54 Mn
Jun 30, 2024 4.56 Mn
Mar 31, 2024 450,000.00
Dec 31, 2023 34.35 Mn
Sep 30, 2023 21,000.00
Jun 30, 2023 1.19 Mn
Mar 31, 2023 44,000.00
Dec 31, 2022 -4.73 Mn
Sep 30, 2022 350,000.00
Jun 30, 2022 14.38 Mn
Mar 31, 2022 1.40 Mn
Dec 31, 2021 -9,000.00
Sep 30, 2021 3.17 Mn
Jun 30, 2021 40.96 Mn
Mar 31, 2021 14.94 Mn
API Access

Tempest Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=TPST&period=max&api_key=YOUR_API_KEY